By the beginning of the 2000s, new drug therapies were developed to give control between recurrences, which extended the life of people and gave them hope.
The more treatment instruments in the toolbox, the better
Dr. Reece notes that the progress in pharmacology has been transforming with regard to the treatment of multiple myeloma.
“We melken elk beetje voordeel uit elk medicijn, zolang het maar duurt, omdat de ziekte terugkeert. Dan, als we een andere behandeling hebben om het te onderdrukken, kunnen we dingen weer op de rails krijgen. Maar de ziekte komt terug, dus we zijn afhankelijk van het hebben van deze verschillende sequentiële behandelingen,” merkt ze op, “voegt ze eraan toe:” Uiteindelijk, hoewel, hoewel, maar, maar, maar de ziekte is dodelijk. ”
The most recent step forward for multiple myeloma in recent years is immunotherapy, which means that immune fabrics, cells or antibodies, helping the body’s own immune system to help recognize and attack cancer cells. In contrast to chemotherapies and other means designed to immediately eliminate cancer cells (which also destroy healthy cells in the process), immunotherapy is not accompanied by the toxicity of traditional cancer therapies.
As experts agree, immunotherapy represents a shift in how we think about treating cancer and other diseases with emerging science.
#therapies #transform #treatment #blood #cancer #extend #lives